Furthermore, CTLA-4negative anti-CD123 CAR T cells demonstrated proliferative capacity and longer survival compared to AML-bearing mice infused with CTLA-4positive anti-CD123 CAR T cells. Here, IL3RA is linked to acute myeloid leukemia.